Pharmaxis Cancer Drug Study Published in Nature Communications
23rd
Mar 23
Release Date: 23/03/2023 9:21am
Pharmaxis cancer drug doubles response rate to standard therapy in blood cancer pre clinical studies
- Nature Communications publishes peer-reviewed data from highly predictive pre clinical models using cells from mylodysplastic syndrome patients
- Best in class results from Combination of PXS-5505 and standard of care demonstrates a strong rationale for treatment of several blood cancers
Categories: News and Media